Skip to main content
In stock | Targeted Therapy (Investigational)

Seliciclib (CDK Inhibitor)

Oncology Type Solid Tumour (Sarcoma)
Drug Class / Mechanism Gamma-Secretase / CDK Inhibitor
No Image
Description

Seliciclib (CDK Inhibitor) is classified as a Gamma-Secretase / CDK Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy (Investigational)
Oncology Type Solid Tumour (Sarcoma)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3